DSpace university logo mark
詳細検索
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > 030 医学部 > 030 紀要 > Acta Medica Nagasakiensia > Volume 30, No. 4 >

Prevention and Control of HBV Infection


ファイル 記述 サイズフォーマット
acta30_04_08_t.pdf287.15 kBAdobe PDF本文ファイル

タイトル: Prevention and Control of HBV Infection
著者: Yano, Michitami
発行日: 1986年 3月20日
引用: Acta medica Nagasakiensia. 1986, 30(4), p.312-316
抄録: HB Vaccine in Japan In Japan, there are three companies which concern themselves in the development of HB Vaccine. Regarding the Vaccines developed by Kitasato Institute and Green Cross co., the licence was given by Ministry of Health and Welfare. After the safety test using Chimpanzees, these two HB Vaccines are going to be on the market and available around the end of 1985. The HB Vaccine developed by Kaketsuken Institute is now asking for the licence of it. Each Vaccine produced by three companies is made from e-Antigen negative Plasma, and it was inactivated by formaline after 10 hrs' heat. sterilization at 60 degrees. The subtype of HBs Antigen of source plasma is adr, and 40μg of HBs Antigen is contained in 1ml of HB Vaccine. One dose of each Vaccine is 0.5ml for adult and 0.25 ml for babies and administrated subcutaneously. The producing method and Alminum content as an adjunct are different in these 3 Vaccines. (Table 1) The positive ratio of anti HBs reaches maximum point after 3rd vaccination, and the mean titer of anti HBs
URI: http://hdl.handle.net/10069/15696
ISSN: 00016055
資料タイプ: Departmental Bulletin Paper
原稿種類: publisher
出現コレクション:Volume 30, No. 4

引用URI : http://hdl.handle.net/10069/15696

このリポジトリに保管されている文献はすべて著作権により保護されています。
印刷やダウンロード等データの複製は、調査研究・教育または学習を目的とする場合に限定されます。

 

Valid XHTML 1.0! Copyright © 2006-2015 長崎大学附属図書館 - お問い合わせ Powerd by DSpace